Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets EXMKT - Delayed Quote USD

Pilot Therapeutics Holdings Inc. (PLTT)

Compare
0.0001
0.0000
(0.00%)
At close: March 12 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2002 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. John W. Crain Vice President of Sales 122k -- 1948
Mr. Ross Consaul Chief Executive Officer -- -- --
Mr. Keith Wakeman President -- -- --
Mr. Steven Greenberg Chief Financial Officer -- -- --
Mr. Scott Derks Chief Operating Officer -- -- --
Mr. Glenn J. Kline Secretary and Director -- -- 1964

Pilot Therapeutics Holdings Inc.

2000 Daniel Island Drive
Charleston, SC 29492
United States
843 329 8500
Sector: 
Industrials
Full Time Employees: 
14

Description

Pilot Therapeutics Holdings Inc. develops and manufactures pharmaceutical products for treatment of dysfunctional lipid metabolism. The company offers Airozin for asthma, PLT 1288 for arthritis, PLT 732 for cardiovascular disease and diabetes, and PLT 2753 for allergic rhinitis. Additionally, it provides clinical trials, personnel recruitment, sales and marketing, and raising capital services. Pilot Therapeutics Holdings Inc. was founded in 1998 and is based in the United States.

Corporate Governance

Pilot Therapeutics Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers